Exact Sciences Corp (EXAS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Exact Sciences Corp (EXAS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7336
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

Exact Sciences Corp (EXAS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Exact Sciences Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Exact Sciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Exact Sciences Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Exact Sciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Exact Sciences Corp, Medical Equipment, Deal Details 11
Asset Purchase 11
Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 11
Venture Financing 12
Armune BioScience Raises USD0.5 Million in Venture Financing 12
Armune BioScience Raises USD5 Million in Series A Venture Financing 13
Armune BioScience Raises USD4 Million in Second and Final Tranche of Series A Financing 14
Armune BioScience to Raise USD25 Million in Series B Financing 15
Armune BioScience Raises Additional USD5.6 Million in Venture Financing 16
Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 17
Armune BioScience Raises USD3.5 Million in Venture Financing 18
Armune BioScience Raises US$1.4 Million In Venture Financing 19
Partnerships 20
Exact Sciences and Pfizer Enter into Co-Promotion Agreement 20
MDxHealth Enters into Agreement with Exact Sciences 21
Aeterna Zentaris Expands its Co-Marketing Agreement with Armune BioScience 22
Equity Offering 23
Exact Sciences Raises USD245 Million in Public Offering of Shares 23
Exact Sciences Prices Public Offering of Shares for USD132 Million 25
Exact Sciences Prices Public Offering of Shares for USD178.5 Million 26
Exact Sciences Prices Public Offering of Shares for USD103 Million 27
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million 28
Exact Sciences Completes Public Offering Of Shares For US$78 Million 30
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 31
Debt Offering 32
Exact Sciences Prices Public Offering of 1% Convertible Senior Notes Due 2025 for USD190 Million 32
Exact Sciences Raises USD690 Million in Public Offering of Senior Notes Due 2025 33
Acquisition 34
Exact Sciences Acquires Armune Bioscience 34
Exact Sciences Corp – Key Competitors 35
Exact Sciences Corp – Key Employees 36
Exact Sciences Corp – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Strategy And Business Planning 39
Aug 14, 2018: University Research Park Breaks Ground on Corporate Headquarters Building for Exact Sciences 39
Financial Announcements 40
Jan 07, 2018: Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017 40
Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests 41
Feb 21, 2017: Exact Sciences reports lower Q4 net loss, provides outlook for 2017 42
Other Significant Developments 43
Aug 23, 2018: Exact Sciences and Pfizer to co-market colorectal cancer diagnosis test 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Exact Sciences Corp, Medical Equipment, Key Facts, 2017 2
Exact Sciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Exact Sciences Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Exact Sciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Exact Sciences Corp, Deals By Market, 2012 to YTD 2018 9
Exact Sciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 11
Armune BioScience Raises USD0.5 Million in Venture Financing 12
Armune BioScience Raises USD5 Million in Series A Venture Financing 13
Armune BioScience Raises USD4 Million in Second and Final Tranche of Series A Financing 14
Armune BioScience to Raise USD25 Million in Series B Financing 15
Armune BioScience Raises Additional USD5.6 Million in Venture Financing 16
Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 17
Armune BioScience Raises USD3.5 Million in Venture Financing 18
Armune BioScience Raises US$1.4 Million In Venture Financing 19
Exact Sciences and Pfizer Enter into Co-Promotion Agreement 20
MDxHealth Enters into Agreement with Exact Sciences 21
Aeterna Zentaris Expands its Co-Marketing Agreement with Armune BioScience 22
Exact Sciences Raises USD245 Million in Public Offering of Shares 23
Exact Sciences Prices Public Offering of Shares for USD132 Million 25
Exact Sciences Prices Public Offering of Shares for USD178.5 Million 26
Exact Sciences Prices Public Offering of Shares for USD103 Million 27
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million 28
Exact Sciences Completes Public Offering Of Shares For US$78 Million 30
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 31
Exact Sciences Prices Public Offering of 1% Convertible Senior Notes Due 2025 for USD190 Million 32
Exact Sciences Raises USD690 Million in Public Offering of Senior Notes Due 2025 33
Exact Sciences Acquires Armune Bioscience 34
Exact Sciences Corp, Key Competitors 35
Exact Sciences Corp, Key Employees 36
Exact Sciences Corp, Subsidiaries 38

List of Figures
Exact Sciences Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Exact Sciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Exact Sciences Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Exact Sciences Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Exact Sciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Exact Sciences Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Exact Sciences Corp (EXAS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prologis Inc (PLD):企業の財務・戦略的SWOT分析
    Prologis Inc (PLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Semiconductor Manufacturing International Corporation
    Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report Summary Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Groupe PSA:企業の戦略・SWOT・財務分析
    Groupe PSA - Strategy, SWOT and Corporate Finance Report Summary Groupe PSA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CLP Holdings Limited:企業の戦略・SWOT・財務分析
    CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Prime Healthcare Services Inc:企業のM&A・事業提携・投資動向
    Prime Healthcare Services Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prime Healthcare Services Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • International SOS Pte Ltd:企業の戦略的SWOT分析
    International SOS Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • TransMontaigne Product Services LLC-石油・ガス分野:企業M&A・提携分析
    Summary TransMontaigne Product Services LLC (TransMontaigne), a subsidiary of NGL Energy Partners LP, is an energy company, which carries out distribution and marketing of a wide range of petroleum products. The company markets several products including unbranded gasoline, diesel fuel, heating oil, …
  • Alps Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AltaGas Ltd (ALA):企業の財務・戦略的SWOT分析
    AltaGas Ltd (ALA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Israel Chemicals Ltd.:企業のM&A・事業提携・投資動向
    Israel Chemicals Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Israel Chemicals Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • CSI Compressco LP (CCLP):企業の財務・戦略的SWOT分析
    Summary CSI Compressco LP (CSI), formerly Compressco Partners LP, a subsidiary of TETRA Technologies Inc, is an oilfield consulting company that offers compression services and equipment for natural gas and oil production, transportation, and storage. The company's products include real-time compres …
  • IOL Chemicals and Pharmaceuticals Ltd (IOLCP):企業の財務・戦略的SWOT分析
    IOL Chemicals and Pharmaceuticals Ltd (IOLCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • RF Surgical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary RF Surgical Systems Inc (RF Surgical Systems), a subsidiary of Medtronic Plc is a medical equipment company that provides retained surgical sponge detection system. The company’s products include RF assure delivery system, RF assure detection system X, and RFDETECT premium. Its RF assures de …
  • Tel-Instrument Electronics Corp.:企業の戦略・SWOT・財務分析
    Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report Summary Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Dana Gas (DANA):企業の財務・戦略的SWOT分析
    Summary Dana Gas is an oil and gas company. It produces natural gas. The company carries out the exploration and production of gas, oil, condensate, LPG and natural gas liquids. It offers processing, transportation, distribution and sales of oil, petroleum and natural gas products. Dana Gas operates …
  • HNB Assurance PLC (HASU.N0000):企業の財務・戦略的SWOT分析
    HNB Assurance PLC (HASU.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Talon Metals Corp.
    Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report Summary Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Chubu Electric Power Co Inc (9502):電力:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …
  • Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆